These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 7514194)
1. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. Blat C; Villaudy J; Binoux M J Clin Invest; 1994 May; 93(5):2286-90. PubMed ID: 7514194 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases. Angelloz-Nicoud P; Harel L; Binoux M Growth Regul; 1996 Sep; 6(3):130-6. PubMed ID: 8894645 [TBL] [Abstract][Full Text] [Related]
3. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability. Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649 [TBL] [Abstract][Full Text] [Related]
4. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors. Reece EA; Wiznitzer A; Le E; Homko CJ; Behrman H; Spencer EM Obstet Gynecol; 1994 Jul; 84(1):88-95. PubMed ID: 7516515 [TBL] [Abstract][Full Text] [Related]
5. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. Reeve JG; Morgan J; Schwander J; Bleehen NM Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401 [TBL] [Abstract][Full Text] [Related]
6. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients? Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human insulin-like growth factor binding proteins 4, 5, and 6: biological and physiochemical characterization. Kiefer MC; Schmid C; Waldvogel M; Schläpfer I; Futo E; Masiarz FR; Green K; Barr PJ; Zapf J Growth Regul; 1993 Mar; 3(1):56-9. PubMed ID: 7683532 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein (IGFBP-3), an inhibitor of serum growth factors other than IGF-I and -II. Liu L; Delbé J; Blat C; Zapf J; Harel L J Cell Physiol; 1992 Oct; 153(1):15-21. PubMed ID: 1381713 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome. Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320 [TBL] [Abstract][Full Text] [Related]
11. Ontogeny of insulin-like growth factor-binding protein-1, -2, and -3: quantitative measurements by radioimmunoassay in human fetal serum. Bang P; Westgren M; Schwander J; Blum WF; Rosenfeld RG; Stangenberg M Pediatr Res; 1994 Oct; 36(4):528-36. PubMed ID: 7529395 [TBL] [Abstract][Full Text] [Related]
12. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors. McCarthy TL; Casinghino S; Centrella M; Canalis E J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403 [TBL] [Abstract][Full Text] [Related]
13. Regulation of human villous trophoblast by insulin-like growth factors and insulin-like growth factor-binding protein-1. Hills FA; Elder MG; Chard T; Sullivan MH J Endocrinol; 2004 Dec; 183(3):487-96. PubMed ID: 15590975 [TBL] [Abstract][Full Text] [Related]
14. Cellular localization and expression of insulin-like growth factors (IGFs) and IGF binding proteins within the epiphyseal growth plate of the ovine fetus: possible functional implications. de los Rios P; Hill DJ Can J Physiol Pharmacol; 1999 Apr; 77(4):235-49. PubMed ID: 10535672 [TBL] [Abstract][Full Text] [Related]
15. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern. Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974 [TBL] [Abstract][Full Text] [Related]
16. Proteolysis of insulin-like growth factor binding protein-3 in serum from pregnant, non-pregnant and fetal rats by matrix metalloproteinases and serine proteases. Wu HB; Lee CY; Rechler MM Horm Metab Res; 1999; 31(2-3):186-91. PubMed ID: 10226801 [TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of insulin-like growth factor-modulated proteolysis of insulin-like growth factor binding protein-4 and -5 by pregnancy-associated plasma protein-A. Gyrup C; Oxvig C Biochemistry; 2007 Feb; 46(7):1972-80. PubMed ID: 17249697 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the insulin-like growth factor (IGF) axis in the serum of maternal and fetal macaques (Macaca mulatta and Macaca fascicularis). Tarantal AF; Gargosky SE Growth Regul; 1995 Dec; 5(4):190-8. PubMed ID: 8745144 [TBL] [Abstract][Full Text] [Related]
19. Decreased ternary complex formation and predominance of a 29 kDa IGFBP-3 fragment in human fetal serum. Bang P; Stangenberg M; Westgren M; Rosenfeld RG Growth Regul; 1994 Jun; 4(2):68-76. PubMed ID: 7524886 [TBL] [Abstract][Full Text] [Related]
20. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT. Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]